The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose.
Where this comes from
- Record sourced from PubMed, PMID 33524290.
- Also identified by DOI 10.7326/ACPJ202102160-015.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Polack FP, Thomas SJ, Kitchin N, et al. <b>Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine.</b> N Engl J Med. 2020;383:2603-15. 33301246.
Medical subject headings
- COVID-19
- Vaccines